An investigation into the effects of diindolylmethane (BioResponse DIM®) supplementation in women with low-grade cervical cytological abnormalities
Not Applicable
Completed
- Conditions
- Cervical neoplasia.CancerCervical
- Registration Number
- ISRCTN47437431
- Lead Sponsor
- Queen Mary and Westfield College, University of London (UK)
- Brief Summary
1. 2012 results in http://www.ncbi.nlm.nih.gov/pubmed/22075942
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 3000
Inclusion Criteria
Women with a first mildly dyskaryotic smear or a second borderline smear taken within the Cervical Screening Wales (CSW) programme will be invited to participate in the trial.
Exclusion Criteria
N/A
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in cervical intra-epithelial neoplasia grade 2 (CIN2) or worse.
- Secondary Outcome Measures
Name Time Method Cytology, lesion size, human papillomavirus (HPV) status (all at 6 months).